glp-1 pcos The dual impact of receptor agonists on metabolic and reproductive health in polycystic ovary syndrome: insights from human and animal trials Superior metabolic improvement of polycystic

Its probably reversible

Obesity is a chronic disease associated with increased risk of obesity-related complications and mortality

There was an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, nephrolithiasis, interstitial nephritis and drug-induced pancreatitis.

Eli Lillys decision to hike the UK list price of its weight-loss drug Mounjaro by as much as 170% isnt just about affordability

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed for diabetes and obesity, exhibit pleiotropic effectsincluding anti-inflammatory, ...

As GLP-1 receptor agonists, these peptide drugs mimic the incretin hormone GLP-1, enhancing glucose-dependent insulin secretion, suppressing glucagon release, delaying gastric emptying, and reducing appetite [9]